SIGA Technologies, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 1.01M | $5.41M | 0.00% | Trimmed-5.9% | 2026-03-31 |
| RenTech | quant | 475.0K | $2.54M | 0.00% | Added+25.6% | 2026-03-31 |
| DEShaw | quant | 456.4K | $2.44M | 0.00% | Trimmed-17.7% | 2026-03-31 |
| TwoSigma | quant | 433.7K | $2.32M | 0.00% | Added+4069.8% | 2026-03-31 |
| Citadel | multi-strat | 37.7K | $201.84K | 0.00% | New | 2026-03-31 |
| FidelityFMR | fundamental | 23.4K | $125.20K | 0.00% | Added+309.9% | 2026-03-31 |
| TRowePrice | fundamental | 63.3K | $339 | 0.00% | Added+36.7% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-04upcoming | — | — | — |
| 2014-03-10 | 0.65 | -0.08 | -112.31% |
| 2013-11-06 | 1.01 | -0.09 | -108.91% |
| 2013-08-05 | 0.04 | -0.06 | -250.00% |
| 2013-05-15 | -0.09 | -0.09 | — |
| 2013-03-06 | 0.02 | -0.06 | -400.00% |
| 2012-09-30 | -0.04 | -0.06 | -50.00% |
| 2012-08-06 | -0.08 | -0.08 | — |
| 2012-05-07 | -0.13 | -0.08 | +38.46% |
| 2012-03-01 | 0.43 | -0.11 | -125.58% |
| 2011-11-08 | -0.07 | — | +100.00% |
| 2011-08-01 | -0.07 | 0.44 | +686.67% |
| 2011-05-05 | -0.05 | -0.09 | -80.00% |
| 2011-03-09 | 0.07 | -0.29 | -514.29% |
| 2010-11-02 | -0.07 | -0.10 | -49.99% |
| 2010-08-05 | -0.08 | -0.10 | -25.00% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| SIGA | +1.74% | -26.53% | -23.40% | -23.03% |
| XLV | +2.97% | -4.83% | -3.44% | +12.62% |
| Alpha (stock − sector) | -1.23% | -21.70% | -19.96% | -35.65% |